Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients.
Publication
, Journal Article
Freemark, M
Published in: J Clin Endocrinol Metab
January 2003
Duke Scholars
Published In
J Clin Endocrinol Metab
DOI
ISSN
0021-972X
Publication Date
January 2003
Volume
88
Issue
1
Start / End Page
3 / 13
Location
United States
Related Subject Headings
- Risk Factors
- Pediatrics
- Humans
- Genetic Predisposition to Disease
- Endocrinology & Metabolism
- Drug Therapy
- Disease Susceptibility
- Diabetes Mellitus, Type 2
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Freemark, M. (2003). Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients. J Clin Endocrinol Metab, 88(1), 3–13. https://doi.org/10.1210/jc.2002-021033
Freemark, Michael. “Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients.” J Clin Endocrinol Metab 88, no. 1 (January 2003): 3–13. https://doi.org/10.1210/jc.2002-021033.
Freemark M. Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients. J Clin Endocrinol Metab. 2003 Jan;88(1):3–13.
Freemark, Michael. “Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients.” J Clin Endocrinol Metab, vol. 88, no. 1, Jan. 2003, pp. 3–13. Pubmed, doi:10.1210/jc.2002-021033.
Freemark M. Pharmacologic approaches to the prevention of type 2 diabetes in high risk pediatric patients. J Clin Endocrinol Metab. 2003 Jan;88(1):3–13.
Published In
J Clin Endocrinol Metab
DOI
ISSN
0021-972X
Publication Date
January 2003
Volume
88
Issue
1
Start / End Page
3 / 13
Location
United States
Related Subject Headings
- Risk Factors
- Pediatrics
- Humans
- Genetic Predisposition to Disease
- Endocrinology & Metabolism
- Drug Therapy
- Disease Susceptibility
- Diabetes Mellitus, Type 2
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine